Evidence method
Level · gp.fundamentals.debt_to_revenue
212.42% · OPTIONAL · NOT_ENOUGH_HISTORY
RHYTHM PHARMACEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
212.42% · OPTIONAL · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-51.90% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.inventory_revenue_ratio
43.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.gross_margin
89.28% · CORE · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.operating_margin
-102.64% · CORE · NOT_ENOUGH_HISTORY
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
89.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.sbc_revenue_ratio
36.67% · OPTIONAL · NOT_ENOUGH_HISTORY
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.